The top 5 ADC startups favoured by venture capital investors

Antibody-drug conjugates (ADC) are booming in the biotech industry this year with mounting investment and M&A deals. Here are five ADC players that have caught the eye of investors in the last 12 months.

Related Keywords

California ,United States ,Switzerland ,San Diego ,China ,Shanghai ,Netherlands ,Copenhagen ,Køavn ,Denmark ,Nijmegen ,Gelderland ,Daiichi Sankyo ,Rutgers New Jersey Medical School ,University Of Strasbourg ,French National Institute Of Health Inserm ,Novo Holdings ,Pfizer ,University Of Copenhagen ,Creation House Program ,Bioinnovation Institute ,Tagworks Pharmaceuticals ,Drug Administration ,Samsung Venture ,Enovo Seeds ,Pontifax Venture Capital ,Duality Biologics ,Eight Roads Ventures ,French National Institute ,Jeito Capital ,Rutgers New Jersey Medical ,Avidity Partners ,Cowen Healthcare ,Philips Healthcare ,Ysios Capital ,Markets Amp Regulations ,Bio Developments ,Antibody Drug Conjugates ,Dc ,Dancer ,Ncology ,